← FDA Drug Approvals (Drugs@FDA)

CITALOPRAM HYDROBROMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2026-03-13

Drug application

FDA Application #

ANDA219985

Application type

Abbreviated New Drug Application (Generic)

Brand name

CITALOPRAM HYDROBROMIDE

Generic name

CITALOPRAM

Active ingredients

CITALOPRAM HYDROBROMIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA LTD

Manufacturer

Aurobindo Pharma Limited

First approval

2026-03-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown